DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 127 filers reported holding DYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,584 | -20.4% | 400 | 0.0% | 0.00% | – |
| Q2 2023 | $4,500 | -2.3% | 400 | 0.0% | 0.00% | – |
| Q1 2023 | $4,608 | +53.6% | 400 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -62.5% | 400 | -50.0% | 0.00% | – |
| Q1 2022 | $8,000 | -20.0% | 800 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -23.1% | 800 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | +62.5% | 800 | +100.0% | 0.00% | – |
| Q2 2021 | $8,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $19,891,505 | 30.79% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $44,363,675 | 23.76% |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $88,573,623 | 13.72% |
| Logos Global Management LP | 2,180,000 | $19,532,800 | 2.61% |
| TCG Crossover Management, LLC | 1,650,150 | $14,785,344 | 2.18% |
| VR Adviser, LLC | 2,173,913 | $19,478,260 | 2.05% |
| Altium Capital Management LP | 315,000 | $2,822,400 | 1.47% |
| Vivo Capital, LLC | 1,035,136 | $9,274,819 | 1.02% |
| Octagon Capital Advisors LP | 692,945 | $6,208,787 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 146,500 | $1,312,640 | 0.88% |